Kimberly Murphy - Jun 23, 2022 Form 4 Insider Report for ORAGENICS INC (OGEN)

Role: CEO and President, Director
Signature: /s/ Mark A. Catchur, as Attorney-in-Fact for Kimberly Murphy
Stock symbol: OGEN
Transactions as of: Jun 23, 2022
Transactions value $: $0
Form type: 4
Date filed: 6/24/2022, 04:15 PM
Previous filing: Jun 9, 2022
Next filing: Aug 10, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	OGEN	Employee Option (Right to Buy)	Award	$0	+800K		$0.00	800K	Jun 23, 2022	Common Stock	800K	$0.30	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents an award of options to purchase shares of the Company's common stock under the Company's 2021 Equity Incentive Plan in connection with the engagement to serve as the Company President and Chief Executive Officer. The options vest as follows: 160,000 options vest on the grant date, 160,000 options vest on December 23, 2022, 160,000 options vest on June 23, 2023, 160,000 options vest on December 23, 2023, and 160,000 options vest on June 23, 2024. The option exercise price is the Company's closing price on the date of grant.

Content

Represents an award of options to purchase shares of the Company's common stock under the Company's 2021 Equity Incentive Plan in connection with the engagement to serve as the Company President and Chief Executive Officer. The options vest as follows: 160,000 options vest on the grant date, 160,000 options vest on December 23, 2022, 160,000 options vest on June 23, 2023, 160,000 options vest on December 23, 2023, and 160,000 options vest on June 23, 2024. The option exercise price is the Company's closing price on the date of grant.